Comments

Macrogenics

MGNXNASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$5.30
-0.08-1.58%
Pre-Market: 7:00 AM EDT
15 minutes delayed
Macrogenics (MGNX) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$40.00
Lowest Price Target1
$4.00
Consensus Price Target1
$14.91

want to know what
the Bulls & Bears Say?

Macrogenics (NASDAQ:MGNX) Stock, Analyst Ratings, Price Targets, Forecasts

Macrogenics Inc has a consensus price target of $14.91 based on the ratings of 14 analysts. The high is $40 issued by SMBC Nikko on February 4, 2022. The low is $4 issued by HC Wainwright & Co. on May 13, 2024. The 3 most-recent analyst ratings were released by BTIG, HC Wainwright & Co., and Barclays on May 24, 2024, May 13, 2024, and May 10, 2024, respectively. With an average price target of $9 between BTIG, HC Wainwright & Co., and Barclays, there's an implied 69.81% upside for Macrogenics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Jan
1
1
Feb
3
1
Mar
0
0
0
0
Apr
1
2
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

BTIG
HC Wainwright & Co.
Barclays
JMP Securities
BMO Capital

1calculated from analyst ratings

Analyst Ratings for Macrogenics

Buy NowGet Alert
05/24/2024Buy Now69.81%BTIG
Kaveri Pohlman
$24 → $9MaintainsBuyGet Alert
05/13/2024Buy Now-24.53%HC Wainwright & Co.
Robert Burns
$16 → $4MaintainsNeutralGet Alert
05/10/2024Buy Now164.15%Barclays
Peter Lawson
$25 → $14MaintainsOverweightGet Alert
05/10/2024Buy Now201.89%JMP Securities
Silvan Tuerkcan
$22 → $16MaintainsMarket OutperformGet Alert
05/10/2024Buy Now50.94%BMO Capital
Etzer Darout
$24 → $8DowngradeOutperform → Market PerformGet Alert
05/10/2024Buy Now—TD Cowen
Boris Peaker
—DowngradeBuy → HoldGet Alert
05/10/2024Buy Now32.08%Stifel
Stephen Willey
$29 → $7DowngradeBuy → HoldGet Alert
04/09/2024Buy Now—TD Cowen
Boris Peaker
—UpgradeHold → BuyGet Alert
04/04/2024Buy Now—JMP Securities
Silvan Tuerkcan
—Reiterates → Market OutperformGet Alert
03/11/2024Buy Now371.7%Citigroup
Yigal Nochomovitz
$13 → $25MaintainsBuyGet Alert
03/11/2024Buy Now315.09%JMP Securities
Silvan Tuerkcan
$16 → $22MaintainsOutperformGet Alert
03/11/2024Buy Now201.89%HC Wainwright & Co.
Robert Burns
$14 → $16MaintainsNeutralGet Alert
03/08/2024Buy Now352.83%BMO Capital
Etzer Darout
$18 → $24MaintainsOutperformGet Alert
03/08/2024Buy Now447.17%Stifel
Stephen Willey
$17 → $29MaintainsBuyGet Alert
03/08/2024Buy Now371.7%Barclays
Peter Lawson
$23 → $25MaintainsOverweightGet Alert
03/04/2024Buy Now352.83%BTIG
Kaveri Pohlman
$12 → $24MaintainsBuyGet Alert
02/29/2024Buy Now333.96%Barclays
Peter Lawson
$12 → $23MaintainsOverweightGet Alert
02/14/2024Buy Now164.15%HC Wainwright & Co.
Robert Burns
$12 → $14DowngradeBuy → NeutralGet Alert
01/24/2024Buy Now201.89%JMP Securities
Silvan Tuerkcan
$10 → $16MaintainsMarket OutperformGet Alert
12/20/2023Buy Now145.28%Citigroup
Yigal Nochomovitz
$7 → $13UpgradeNeutral → BuyGet Alert
11/27/2023Buy Now220.75%Stifel
Jonathan Block
 → $17ReiteratesBuy → BuyGet Alert
11/13/2023Buy Now126.42%HC Wainwright & Co.
Robert Burns
$14 → $12MaintainsBuyGet Alert
11/07/2023Buy Now126.42%Guggenheim
Charles Zhu
 → $12UpgradeNeutral → BuyGet Alert
08/10/2023Buy Now164.15%HC Wainwright & Co.
Robert Burns
 → $14ReiteratesBuy → BuyGet Alert
05/11/2023Buy Now88.68%JMP Securities
Silvan Tuerkcan
$8 → $10MaintainsMarket OutperformGet Alert
04/03/2023Buy Now164.15%HC Wainwright & Co.
Robert Burns
 → $14Reiterates → BuyGet Alert
03/21/2023Buy Now126.42%BTIG
Kaveri Pohlman
$6 → $12MaintainsBuyGet Alert
03/20/2023Buy Now164.15%HC Wainwright & Co.
Robert Burns
$12 → $14MaintainsBuyGet Alert
03/17/2023Buy Now—Guggenheim
Charles Zhu
—DowngradeBuy → NeutralGet Alert
03/16/2023Buy Now50.94%JMP Securities
Silvan Tuerkcan
 → $8Reiterates → Market OutperformGet Alert
01/19/2023Buy Now50.94%JMP Securities
Silvan Tuerkcan
$18 → $8MaintainsMarket OutperformGet Alert
11/23/2022Buy Now32.08%Citigroup
Yigal Nochomovitz
$16 → $7DowngradeBuy → NeutralGet Alert
11/23/2022Buy Now126.42%Guggenheim
Charles Zhu
 → $12UpgradeNeutral → BuyGet Alert
11/22/2022Buy Now—Cowen & Co.
Boris Peaker
—DowngradeOutperform → Market PerformGet Alert
11/14/2022Buy Now201.89%BMO Capital
Etzer Darout
$5.7 → $16UpgradeMarket Perform → OutperformGet Alert
11/07/2022Buy Now126.42%HC Wainwright & Co.
Robert Burns
$11 → $12MaintainsBuyGet Alert
10/18/2022Buy Now107.55%HC Wainwright & Co.
Robert Burns
$10 → $11MaintainsBuyGet Alert
09/12/2022Buy Now88.68%HC Wainwright & Co.
Robert Burns
$35 → $10MaintainsBuyGet Alert
08/29/2022Buy Now201.89%Citigroup
Yigal Nochomovitz
$13 → $16MaintainsBuyGet Alert
08/09/2022Buy Now126.42%SVB Leerink
Jonathan Chang
$15 → $12MaintainsOutperformGet Alert
08/09/2022Buy Now50.94%Barclays
Peter Lawson
$18 → $8MaintainsOverweightGet Alert
07/12/2022Buy Now277.36%JMP Securities
Silvan Tuerkcan
$24 → $20MaintainsMarket OutperformGet Alert
07/12/2022Buy Now-24.53%BMO Capital
Etzer Darout
$31 → $4DowngradeOutperform → Market PerformGet Alert
07/11/2022Buy Now-24.53%BMO Capital
Etzer Darout
$31 → $4DowngradeOutperform → Market PerformGet Alert
05/05/2022Buy Now—Guggenheim
Charles Zhou
—DowngradeBuy → NeutralGet Alert
05/04/2022Buy Now—Guggenheim
Charles Zhu
—DowngradeBuy → NeutralGet Alert
05/04/2022Buy Now560.38%HC Wainwright & Co.
Robert Burns
$41 → $35MaintainsBuyGet Alert
05/04/2022Buy Now183.02%SVB Leerink
Jonathan Chang
$23 → $15MaintainsOutperformGet Alert
02/28/2022Buy Now296.23%Citigroup
Yigal Nochomovitz
$23 → $21UpgradeNeutral → BuyGet Alert
02/25/2022Buy Now333.96%SVB Leerink
Jonathan Chang
$40 → $23MaintainsOutperformGet Alert
02/11/2022Buy Now484.91%BMO Capital
Etzer Darout
 → $31Initiates → OutperformGet Alert
02/04/2022Buy Now654.72%SMBC Nikko
David Dai
 → $40Initiates → OutperformGet Alert
11/03/2021Buy Now616.98%JMP Securities
Silvan Tuerkcan
—MaintainsMarket OutperformGet Alert
10/19/2021Buy Now635.85%JMP Securities
Silvan Tuerkcan
—Initiates → Market OutperformGet Alert

FAQ

Q

What is the target price for Macrogenics (MGNX) stock?

A

The latest price target for Macrogenics (NASDAQ:MGNX) was reported by BTIG on May 24, 2024. The analyst firm set a price target for $9.00 expecting MGNX to rise to within 12 months (a possible 69.81% upside). 24 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Macrogenics (MGNX)?

A

The latest analyst rating for Macrogenics (NASDAQ:MGNX) was provided by BTIG, and Macrogenics maintained their buy rating.

Q

When was the last upgrade for Macrogenics (MGNX)?

A

The last upgrade for Macrogenics Inc happened on April 9, 2024 when TD Cowen raised their price target to N/A. TD Cowen previously had a hold for Macrogenics Inc.

Q

When was the last downgrade for Macrogenics (MGNX)?

A

The last downgrade for Macrogenics Inc happened on May 10, 2024 when BMO Capital changed their price target from $24 to $8 for Macrogenics Inc.

Q

When is the next analyst rating going to be posted or updated for Macrogenics (MGNX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Macrogenics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Macrogenics was filed on May 24, 2024 so you should expect the next rating to be made available sometime around May 24, 2025.

Q

Is the Analyst Rating Macrogenics (MGNX) correct?

A

While ratings are subjective and will change, the latest Macrogenics (MGNX) rating was a maintained with a price target of $24.00 to $9.00. The current price Macrogenics (MGNX) is trading at is $5.30, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch